NSG 533 EXAM 1 - WILKES
ADVANCED PHARMACOLOGY
(2026) ACTUAL QUESTIONS &
LATEST MOCK PRACTICE SET
160 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NSG 533 EXAM 1 - WILKES ADVANCED PHARMACOLOGY (2026) ACTUAL QUESTIONS & STUDY GUIDE |
GUARANTEE PASS. It contains 160 carefully selected questions that reflect the most current exam content and
testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 160 Questions
Foundations - Application - NSG 533 1 Wilkes Advanced Pharmacology 2026 Actual & Study Guide
Guarantee PASS NSG 533 1 Wilkes Advanced Pharmacology 2026 Actual & Study Guide Guarantee PASS
University
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Prescribed 1-40 Warfarin, Likely, Started, Effect, Inhibitor
Likely 41-80 Appropriate, Started, Prescribed, Toxicity, Digoxin
Started 81-120 Prescribed, Effect, Explains, Mechanism, Warfarin
Warfarin 121-160 Prescribed, Requires, Failure, Combination, Heart
TOTAL 160 All questions include answers and detailed rationales
,Section A - Prescribed
Q1.
A patient on warfarin for atrial fibrillation requires an antibiotic. Which antimicrobial is
most likely to significantly increase the INR through CYP2C9 inhibition, necessitating a
dose reduction of warfarin?
A. Azithromycin B. Ciprofloxacin
C. Doxycycline D. Clindamycin
Correct: B - Ciprofloxacin
Rationale:Ciprofloxacin inhibits CYP2C9, the enzyme that metabolizes the S-enantiomer of
warfarin, leading to increased warfarin levels and INR. Azithromycin and doxycycline have
minimal CYP interactions, and clindamycin is not a significant CYP inhibitor. This interaction
requires close INR monitoring and possible warfarin dose adjustment.
Q2.
A patient with type 2 diabetes and stage 3 CKD is being started on an SGLT2 inhibitor.
Which laboratory parameter is most critical to monitor before initiation and during
therapy?
A. Serum creatinine and eGFR B. Liver function tests
C. Serum potassium D. Serum cortisol
Correct: A - Serum creatinine and eGFR
Rationale:SGLT2 inhibitors can cause acute kidney injury and are contraindicated in eGFR
<30 mL/min/1.73m². Monitoring renal function is essential to assess appropriateness and
detect deterioration. Liver function, potassium, and cortisol are not the primary monitoring
parameters for these agents.
Q3.
A patient with severe hypertension is started on labetalol. Which mechanism of action
best explains its antihypertensive effect?
A. Selective alpha-1 blockade only B. Non-selective beta blockade with intrinsic
sympathomimetic activity
C. Combined alpha-1 and beta blockade D. Central alpha-2 agonist activity
Correct: C - Combined alpha-1 and beta blockade
Page 3
, Section A - Prescribed
Rationale: Labetalol is a combined alpha-1 and non-selective beta blocker. Alpha-1 blockade
causes vasodilation, while beta blockade reduces cardiac output, leading to a synergistic
antihypertensive effect. It is not selective alpha-1, does not have ISA, and is not a central
alpha-2 agonist.
Q4.
A patient who is a poor metabolizer of CYP2D6 is prescribed codeine. What is the primary
clinical risk?
A. Enhanced analgesic effect due to B. Reduced analgesic effect and potential
increased morphine levels for toxicity from accumulation of prodrug
C. Increased risk of serotonin syndrome D. Hepatotoxicity due to accumulation of
toxic metabolites
Correct: B - Reduced analgesic effect and potential for toxicity from accumulation of
prodrug
Rationale:Codeine is a prodrug that requires CYP2D6 conversion to morphine for its
analgesic effect. Poor metabolizers lack this enzyme activity, leading to insufficient morphine
production and reduced efficacy. They do not accumulate morphine, but rather the inactive
codeine, which can cause side effects without pain relief. Serotonin syndrome is not a primary
risk, and hepatotoxicity is not typical.
Q5.
A patient is on digoxin and furosemide. Which electrolyte imbalance is most likely to
precipitate digoxin toxicity?
A. Hyperkalemia B. Hypokalemia
C. Hypercalcemia D. Hypomagnesemia
Correct: B - Hypokalemia
Rationale:Hypokalemia increases the binding of digoxin to Na+/K+-ATPase, potentiating its
effects and leading to toxicity. Furosemide causes potassium loss, making hypokalemia a
common precipitant. Hyperkalemia actually reduces digoxin binding, while hypercalcemia and
hypomagnesemia also can increase toxicity, but hypokalemia is the classic and most common
trigger.
Q6.
A patient with an allergic reaction is given epinephrine. Which receptor activation is
primarily responsible for the bronchodilation and vasoconstriction that alleviate
anaphylaxis?
A. Alpha-1 and beta-2 B. Beta-1 and beta-2
Page 4
ADVANCED PHARMACOLOGY
(2026) ACTUAL QUESTIONS &
LATEST MOCK PRACTICE SET
160 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NSG 533 EXAM 1 - WILKES ADVANCED PHARMACOLOGY (2026) ACTUAL QUESTIONS & STUDY GUIDE |
GUARANTEE PASS. It contains 160 carefully selected questions that reflect the most current exam content and
testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 160 Questions
Foundations - Application - NSG 533 1 Wilkes Advanced Pharmacology 2026 Actual & Study Guide
Guarantee PASS NSG 533 1 Wilkes Advanced Pharmacology 2026 Actual & Study Guide Guarantee PASS
University
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Prescribed 1-40 Warfarin, Likely, Started, Effect, Inhibitor
Likely 41-80 Appropriate, Started, Prescribed, Toxicity, Digoxin
Started 81-120 Prescribed, Effect, Explains, Mechanism, Warfarin
Warfarin 121-160 Prescribed, Requires, Failure, Combination, Heart
TOTAL 160 All questions include answers and detailed rationales
,Section A - Prescribed
Q1.
A patient on warfarin for atrial fibrillation requires an antibiotic. Which antimicrobial is
most likely to significantly increase the INR through CYP2C9 inhibition, necessitating a
dose reduction of warfarin?
A. Azithromycin B. Ciprofloxacin
C. Doxycycline D. Clindamycin
Correct: B - Ciprofloxacin
Rationale:Ciprofloxacin inhibits CYP2C9, the enzyme that metabolizes the S-enantiomer of
warfarin, leading to increased warfarin levels and INR. Azithromycin and doxycycline have
minimal CYP interactions, and clindamycin is not a significant CYP inhibitor. This interaction
requires close INR monitoring and possible warfarin dose adjustment.
Q2.
A patient with type 2 diabetes and stage 3 CKD is being started on an SGLT2 inhibitor.
Which laboratory parameter is most critical to monitor before initiation and during
therapy?
A. Serum creatinine and eGFR B. Liver function tests
C. Serum potassium D. Serum cortisol
Correct: A - Serum creatinine and eGFR
Rationale:SGLT2 inhibitors can cause acute kidney injury and are contraindicated in eGFR
<30 mL/min/1.73m². Monitoring renal function is essential to assess appropriateness and
detect deterioration. Liver function, potassium, and cortisol are not the primary monitoring
parameters for these agents.
Q3.
A patient with severe hypertension is started on labetalol. Which mechanism of action
best explains its antihypertensive effect?
A. Selective alpha-1 blockade only B. Non-selective beta blockade with intrinsic
sympathomimetic activity
C. Combined alpha-1 and beta blockade D. Central alpha-2 agonist activity
Correct: C - Combined alpha-1 and beta blockade
Page 3
, Section A - Prescribed
Rationale: Labetalol is a combined alpha-1 and non-selective beta blocker. Alpha-1 blockade
causes vasodilation, while beta blockade reduces cardiac output, leading to a synergistic
antihypertensive effect. It is not selective alpha-1, does not have ISA, and is not a central
alpha-2 agonist.
Q4.
A patient who is a poor metabolizer of CYP2D6 is prescribed codeine. What is the primary
clinical risk?
A. Enhanced analgesic effect due to B. Reduced analgesic effect and potential
increased morphine levels for toxicity from accumulation of prodrug
C. Increased risk of serotonin syndrome D. Hepatotoxicity due to accumulation of
toxic metabolites
Correct: B - Reduced analgesic effect and potential for toxicity from accumulation of
prodrug
Rationale:Codeine is a prodrug that requires CYP2D6 conversion to morphine for its
analgesic effect. Poor metabolizers lack this enzyme activity, leading to insufficient morphine
production and reduced efficacy. They do not accumulate morphine, but rather the inactive
codeine, which can cause side effects without pain relief. Serotonin syndrome is not a primary
risk, and hepatotoxicity is not typical.
Q5.
A patient is on digoxin and furosemide. Which electrolyte imbalance is most likely to
precipitate digoxin toxicity?
A. Hyperkalemia B. Hypokalemia
C. Hypercalcemia D. Hypomagnesemia
Correct: B - Hypokalemia
Rationale:Hypokalemia increases the binding of digoxin to Na+/K+-ATPase, potentiating its
effects and leading to toxicity. Furosemide causes potassium loss, making hypokalemia a
common precipitant. Hyperkalemia actually reduces digoxin binding, while hypercalcemia and
hypomagnesemia also can increase toxicity, but hypokalemia is the classic and most common
trigger.
Q6.
A patient with an allergic reaction is given epinephrine. Which receptor activation is
primarily responsible for the bronchodilation and vasoconstriction that alleviate
anaphylaxis?
A. Alpha-1 and beta-2 B. Beta-1 and beta-2
Page 4
